|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
JAB Cosmetics B.V. OOSTERDOKSSTRAAT 80 AMSTERDAM, P7 NL 1011 DK |
X | |||
Agnaten SE ROOSEVELTPLATZ 4-5 TOP 10 VIENNA, C4 A-1090 |
X | |||
Lucresca SE ROOSEVELTPLATZ 4-5 TOP 10 VIENNA, C4 A-1090 |
X | |||
JAB Holdings B.V. OOSTERDOKSSTRAAT 80 AMSTERDAM, P7 NL 1011 DK |
X |
/s/ Joachim Creus and /s/ Markus Hopmann as Authorized Representatives | 11/20/2018 | |
**Signature of Reporting Person | Date | |
/s/ Joachim Creus and /s/ Markus Hopmann as Authorized Representatives | 11/20/2018 | |
**Signature of Reporting Person | Date | |
/s/ Constantin Thun-Hohenstein and /s/ Dietmar Guetter as Authorized Representatives | 11/20/2018 | |
**Signature of Reporting Person | Date | |
/s/ Constantin Thun-Hohenstein and /s/ Merel Broers as Managing Directors | 11/20/2018 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Purchases made in open market transactions in accordance with Rule 10b-18 of the Securities Exchange Act of 1934, as amended. |
(2) | The shares were purchased in multiple transactions on November 19, 2018 at actual purchase prices ranging from $9.115 to $9.48 per share, exclusive of any fees, commissions or other expenses. The price reported reflects the weighted average purchase price for the transactions. The Reporting Persons undertake to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. |
(3) | The shares were purchased in multiple transactions on November 20, 2018 at actual purchase prices ranging from $8.61 to $9.07 per share, exclusive of any fees, commissions or other expenses. The price reported reflects the weighted average purchase price for the transactions. The Reporting Persons undertake to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. |